期刊文献+

长链非编码RNA MIAT与肿瘤关系的研究进展 被引量:5

Research progress on long noncoding RNA MIAT in human carcinomas
下载PDF
导出
摘要 长链非编码RNAs是人类正常功能活动的调节因子,也是不同肿瘤发展过程的控制因子。研究表明,lncRNAs的失调涉及细胞的不同行为,包括增殖,凋亡,迁移,侵袭和上皮间质转化等。作为明星分子的lncRNA之一,MIAT的异常表达存在于不同的肿瘤中,包括肺癌、乳腺癌、胃癌、肝癌和前列腺癌等。MIAT是一种新型肿瘤相关lncRNA,其临床应用的潜在价值巨大,有望成为新的肿瘤生物标志物和治疗靶点。本文总结了目前关于MIAT在肿瘤发生发展过程中的生物功能和相关机制。 Long noncoding RNAs( lncRNAs) are involved in the regulation of normal physiological processes in humans,while also participating in the development and progression of different cancers. Investigations have indicated that the deregulation of lncRNAs is involved in diverse malignant cellular processes,such as proliferation,anti-apoptosis,migration,invasion,and epithelial-to-mesenchymal transition. A major lncRNA candidate for involvement in cancer is MIAT,the aberrant expression of which has been observed in multiple cancers and functions as an oncogenic factor,including in lung cancer,breast cancer,gastric cancer,liver cancer,and prostate cancer. MIAT thus has immense potential value in clinical applications,holding promise as a biomarker and therapeutic target. This work summarizes current knowledge of the biological functions and underlying mechanisms of MIAT in the development and progression of cancers.
作者 孙程 黄立宁 李景林 李正龙 姜兴明 崔云甫 SUN Cheng, HUANG Lining, LI Jinglin, LI Zhenglong, JIANG Xingming , CUI Yunfu(Department of Hepatopancreatobiliary Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China)
出处 《中国比较医学杂志》 CAS 北大核心 2018年第8期124-128,共5页 Chinese Journal of Comparative Medicine
基金 国家自然科学基金(81602088) 中国博士后科学基金(2017M621305) 黑龙江省卫生计生委科研课题(2016-049) 黑龙江省博士后资助课题(LBH-Z16096) 哈尔滨医科大学创新科学研究基金(2016LCZX09)
关键词 长链非编码RNA MIAT 肿瘤 基因 表达调控 IncRNA MIAT cancer gene expression regulation
  • 相关文献

参考文献6

二级参考文献50

  • 1孙庆国,李永哲,刘镭,孙国军,李军红.核包膜蛋白gp210自身抗原基因的克隆、表达、纯化及其临床应用[J].中国实验诊断学,2007,11(10):1343-1346. 被引量:3
  • 2Feng Yang,Xuchao Xue,Jianwei Bi,Luming Zheng,Kangkang Zhi,Yan Gu,Guoen Fang.Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma[J].Journal of Cancer Research and Clinical Oncology.2013(3)
  • 3Laursen L. A preventable cancer[J]. Nature,2014,516 (7529) :$2-3.
  • 4Harries LW. Long non-coding RNAs andhuman disease[J]. Biochem Soc Trans, 2012,40(4) : 902-906.
  • 5Zou H,Shao CX,Zhou QY,et al. The role of lncRNAs in hepatocellular carcinoma:opportunities as novel targets for pharmacological intervention [J]. Expert Rev Gastroenterol Hepatol,2016, 10(3) :331-340.
  • 6Wang J,Sun J,Wang J,et al. Long noncoding RNAs in gastric cancer: functions and clinical applications [J]. Onco Targets Ther, 2016,9 (2016) : 681-697.
  • 7Mei D,Song H,Wang K,et al. Up-regulation of SUMO1 pseudogene 3(SUMO1P3)in gastric cancer and its clinical association [J]. Med Oncol,2013,30(4):709-714.
  • 8Zhan Y, Liu Y, Wang C, et al. Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer [J]. Oncotarget, 2016,7(13) : 16038-16048.
  • 9Li C, Chen J, Zhang K, et al. Progress and Prospects of Long Noncoding RNAs(lncRNAs)in Hepatocellular Carci- noma [J]. Cell Physiol Biochem, 2015,36(2) : 423-434.
  • 10Zhao J, Greene CM, Gray SG, et al. Long noncoding RNAs in liver cancer [J]. Expert Opin Ther Targets,2014,18(10): 1207-1218.

共引文献11

同被引文献28

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部